Fortrea Holdings Inc. (FTRE) vs Viridian Therapeutics, Inc. (VRDN)
A side-by-side comparison of Fortrea Holdings Inc. and Viridian Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
FTRE
Fortrea Holdings Inc.
$20.78HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
VRDN
Viridian Therapeutics, Inc.
$18.22HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — FTRE vs VRDN
growth of $100 · dividends reinvested · last 3yFTRE -34.0% (-12.9%/yr)VRDN -31.8% (-12.0%/yr)VRDN compounded faster over this window
FTRE VRDN
FTRE vs VRDN: by the numbers
- •VRDN is the larger company ($2.06B vs $1.98B market cap).
- •Both run net losses; FTRE's is the smaller (-3.18% vs -544.06% net margin).
- •VRDN grew revenue faster over the past five years (93.92% vs 1.09% CAGR).
Metrics side by side
Valuation
| Metric | FTRE | VRDN |
|---|---|---|
| Forward P/E | 24.71 | N/A |
| P/S ratio | 0.74 | 29.02 |
| P/B ratio | 3.77 | 3.66 |
| EV / EBITDA | 32.76 | N/A |
| FCF yield | 7.62% | N/A |
Profitability
| Metric | FTRE | VRDN |
|---|---|---|
| Gross margin | 17.11% | 99.55% |
| Operating margin | 0.41% | -512.91% |
| Net margin | -3.18% | -544.06% |
| ROE | -16.25% | -58.45% |
| ROIC | 0.62% | -39.18% |
Growth (annualized)
| Metric | FTRE | VRDN |
|---|---|---|
| Revenue CAGR (5Y) | 1.09% | 93.92% |
| FCF CAGR (5Y) | -12.98% | N/A |
| Total return CAGR (5Y) | N/A | 1.64% |
Frequently asked
- Which has grown faster, FTRE or VRDN?
- Over the past five years, VRDN grew revenue faster — FTRE at a 1.09% CAGR versus VRDN at 93.92%.
Go deeper
Dig into the metrics
Fortrea ROEViridian Therapeutics ROEFortrea operating marginViridian Therapeutics operating marginFortrea revenue growthViridian Therapeutics revenue growthFortrea free cash flowViridian Therapeutics free cash flow
Fortrea & Viridian Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.